IVM With Low Cost Priming, Enhanced Oocyte Recovery, and Delayed Transfer

Launched by BRUCE ROSE, MD · Oct 31, 2019

Keywords

ClinConnect Summary

This clinical trial is studying a new approach to help women with Polycystic Ovary Syndrome (PCOS) achieve pregnancy through a method called In Vitro Maturation (IVM). The goal is to improve the success of getting pregnant by using specific techniques, such as a special needle to collect eggs and lower doses of certain medications. Participants will also have their embryos transferred at a later time, which is different from many standard practices. To be eligible, women need to have a specific pattern in their ovaries seen during an ultrasound, including having more than 25 small follicles and a hormone level above a certain point.

Women aged 18 to 40 who meet these criteria might be able to join the study. Participants can expect to receive personalized care during the egg retrieval process and follow-up treatment. It’s important to note that women with a high body mass index (BMI) or certain medical conditions that could complicate pregnancy are not eligible for this trial. Overall, this study aims to provide a promising option for women struggling with PCOS and looking to conceive.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • PCO pattern with \> 25 antral follicles
• • AMH \> 3.5
• Exclusion Criteria:
• • BMI \> 35
• • body morphology making transvaginal retrieval difficult or impossible
• • complicating medical condition making pregnancy or IVF relatively contra-indicated